Log In
Print
BCIQ
Print
Print this Print this
 

APO010

  Manage Alerts
Collapse Summary General Information
Company Topotarget A/S
DescriptionRecombinant fusion protein derived from the pro-apoptotic human Fas ligand (FasL) protein
Molecular Target Fas receptor (CD95)
Mechanism of ActionFas receptor (CD95) agonist
Latest Stage of DevelopmentPhase I
IndicationCancer
Partner

Oncology Venture ApS
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today